Difference between revisions of "Lumiere Biologics/Infobox"
Jump to navigation
Jump to search
imported>Sub-Pulse |
imported>Sub-Pulse |
||
| Line 3: | Line 3: | ||
| '''Purpose:''' | | '''Purpose:''' | ||
| 'Legitimate' Biotech Company | | 'Legitimate' Biotech Company | ||
| − | |||
| | | | ||
| − | |||
| − | |||
| | | | ||
| − | |||
| − | |||
| | | | ||
| − | |||
| | | | ||
| '''Financial Profile:''' | | '''Financial Profile:''' | ||
Revision as of 18:27, 30 September 2014
| Purpose: | 'Legitimate' Biotech Company | Financial Profile: | The Ueda Family, specifically Dr. Hideki Ueda, are Majority Shareholders of Lumiere Biologics's IPO, the shares are divided along lines of Class A and Class B shares with Class A shares equaling 10 votes to the value of 1 in the case of a Class B. Almost all of the control in the hands of the C.E.O. who remains invested in the daily activities. That said there is a board of directors which has been appointed to handle various facets of the company. |
